Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Future Cardiology|November 29, 2021
Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable anginaJuan Tamargo, Jose Lopez-Sendon
European Cardiology|October 4, 2021
ISCHEMIA Trial: Key Questions and AnswersJose Lopez-Sendon, Raúl Moreno, Juan Tamargo
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 30, 2010
Atrial flutter ablation through the azygous continuation in a patient with inferior vena cava interruptionArmando Pérez-Silva, Jose L Merino, Rafael Peinado, et al.
Current Medical Research and Opinion|July 16, 2014
An analysis of TRITON-TIMI 38, based on the 12 month recommended length of therapy in the European label for prasugrelRobert Wilcox, Kamran Iqbal, Tim Costigan, et al.
Angiology|August 29, 2018
Sta Ble Angina: Pe Rcept Ion of Nee Ds, Quality of Life and Mana Gem Ent of Patients (BRIDGE Study)-A Multinational European Physician SurveyGiuseppe Ambrosio, Peter Collins, Ralf Dechend, et al.
European Journal of Internal Medicine|November 10, 2019
Impact of stable angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 surveyAthanasios J Manolis, Giuseppe Ambrosio, Peter Collins, et al.
Clinical Cardiology|October 27, 2006
Aldosterone blockade in post-acute myocardial infarction heart failureBertram Pitt, Roberto Ferrari, Mihai Gheorghiade, et al.
The American Journal of Medicine|February 3, 2009
Predictors and implications of Q-waves in ST-elevation acute coronary syndromesTroy LaBounty, Hitinder S Gurm, Shaun G Goodman, et al.
European Heart Journal. Acute Cardiovascular Care|April 30, 2015
Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trialUwe Zeymer, Gilles Montalescot, Diego Ardissino, et al.
Journal of the American College of Cardiology|February 15, 2005
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trialJohn McMurray, Lars Køber, Michele Robertson, et al.
Pageof 8